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by immunization wNNith sedimentable materials
inactivated with formalin. Further data
will be presented on the effect of immuniza-
tion on other parameters of infection such
as viraemia and changes in antibody titres
during the course of the disease.
SURFACE IMMUNOLOGICAL MARK-
ERS IN ACUTE MYELOBLASTIC LEU-
KAEMIA. G. M. TAYLOR, C. B. FREEMAN,
J. ESCUDER and R. HARRIS, Department of
Medical Genetics, St Mary's Hospital, Man-
chester.
Before treatment, peripheral blood leuco-
cytes from patients with acute myeloblastic
leukaemia (AML) form few T and B cell
rosettes compared with normal individuals,
and AML blasts do not themselves form
rosettes, unlike a minority of cases of acute
lymphoblastic leukaemia in which T rosette
forming cells are known to occur. A large
but variable proportion of peripheral leuco-
cytes from patients with untreated AML
possess surface immunoglobulin detected by
both direct and indirect immunofluorescence.
The pattern of fluorescent staining on
AML blasts differs from that seen on CLL
cells, and also in contrast in vitro with anti-
human immunoglobulin serum. Surface im-
munoglobulin on AML blasts may represent
tumour associated antibody or immune
complex.
Our results suggest that the proportion
of rosette forming cells, and of cells with
surface immunoglobulin can be used as a
diagnostic aid for patients with AML.
TISSUE CULTURE OF MALIGNANT
EFFUSIONS AND THEIR USEFUL-
NESS AS TARGET CELLS IN CYTO-
TOXICITY CELLS. R. H. WHITEHEAD,
University Department of Surgery, Welsh
National School of Medicine, Cardiff.
Breast tumours pose special problems for
those seeking to study the immune respon-
siveness of patients to their tumours. It is
difficult, if not impossible, to culture breast
cancer cells itn vitro. This has led previous
workers studying lymphocyte cytotoxicity
to use cells derived from effusions from
patient,s Mwithl advanced breast cancer. This
wN-as donie )ecause of thle belief that pleuri:al
effusion cells were free of fibroblasts and
were most probably tumour cells.
Comparative cytotoxicity tests have been
performed using cells derived from pleural
effusions from breast cancer patients and
cells derived from ascites from colon car-
cinoma patients. Cells derived from a
malignant melanoma have also been used
as target cells. Lymphocytes from patients
with breast cancer, colon cancer and melan-
oma have been tested against their cells.
These tests failed to show any tumour
specific cytotoxicity (except in the case of
melanoma), suggesting that the cells derived
from these effusions are ofnormal origin.
CELL MEDIATED IMMUNOREACTI-
VITY IN HUMAN LUNG NEOPLASIA.
B. M. VOSE and M. MOORE, Immunology
Department, Paterson Laboratories, Man-
chester.
The relative susceptibilities of various
tissue culture cells derived principally from
malignant, normal and foetal lung tissues,
to cytolysis by leucocytes from patients with
different histological types of lung cancer
were investigated using an in vitro micro-
cytotoxicity assay for cell mediated im-
munity.
Target cells derived from 12- to 17-week
old embryo lungs and from pulmonary
tumours of different histological types were
most susceptible to the cytotoxic action of
lung cancer patients' leucocytes, while a
lower but significant frequency of positive
reactions has also been observed against
cells originating from non-malignant pul-
monary tissue.
It is concluded that lung tumour cells
may express tumour associated antigens
but their nature and specificity remain to
be elucidated.
AN ATTEMPT TO IDENTIFY STIMU-
LATORY SUBSTANCES INTERFER-
ING WITH A TWO STAGE MACRO-
PHAGE MIGRATION INHIBITION
(MMI) ASSAY AND TO ASSESS IM-
MUNOCOMPETENCE. J. G. AASKOV
and H. M. ANTHONY, Department of Ex-
perimental Pathology and Cancer Researchl,
University of Leeds.
An iInlprove(l two-stage MIA11 test lhas
b)eeli developed to ineasure the primiary
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